ProfileGDS4095 / 242465_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 40% 34% 39% 44% 41% 40% 32% 40% 27% 33% 34% 30% 35% 33% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.7962240
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.5134634
GSM709765LY2 SRC1-siRNA untreated rep32.7327939
GSM709771LY2 SRC1-siRNA untreated rep12.9610944
GSM709772LY2 SRC1-siRNA untreated rep22.8077241
GSM709775LY2 SRC1-siRNA untreated rep42.7519140
GSM709764LY2 control-siRNA tamoxifen treated rep22.4458632
GSM709766LY2 control-siRNA tamoxifen treated rep32.7611540
GSM709768LY2 control-siRNA tamoxifen treated rep12.2532327
GSM709777LY2 control-siRNA tamoxifen treated rep42.4922633
GSM709770LY2 control-siRNA untreated rep32.4740134
GSM709773LY2 control-siRNA untreated rep12.3753530
GSM709774LY2 control-siRNA untreated rep22.5304135
GSM709776LY2 control-siRNA untreated rep42.4753533